Aspirin And Dipyridamole Capsule, Extended Release
Product Images NDC 16714-964

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Dipyridamole (NDC 16714-964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

This is a drug called Aspirin and Extended-Release Dipyridamole that comes in a unit-of-use container that contains 60 capsules. Each capsule contains 25 mg of aspirin and 200 mg of extended-release dipyridamole for treatment. It is recommended to be stored at a temperature between 20°C to 25°C and protected from excessive moisture. Pharmacists are advised to dispense in the unit-of-use container provided by the manufacturer. This drug is manufactured by Dr. Redy's Laboratories Limited in India and distributed by Northstar Rx LLC from Memphis, TN.*

FDA Label Image

Figure (Figure)

The text is a table showing the cumulative stroke rates for different treatment groups over a period of months. The treatment groups include extended-release dipyridamole, aspirin, and placebo. The dosage regimen for all treatment groups is twice a day.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.